Remicov
Remdesivir INN
ANTIVIRAL
INDICATION
Indication | Patient Category | Recommended dose |
Indicated for the treatment Covid-19 patients requiring hospitalization | Adults & Children > 40 Kg | Day 1: 200 mg IV infusionDay 2 & thereafter: 100 mg IV per day |
DOSAGE AND ADMINISTRATION
Patients | Key Patient Factors | Loading Dose | Maintenance Dose | Clinical Considerations |
Adult & Pediatric Patients > 40 kg | Mechanical Ventilation and/or ECMO | 200 mg IV on day 1 | 100 mg IV for 9 days | |
No mechanical ventilation or ECMO | 200 mg IV on day 1 | 100 mg IV for 4 days | If no clinical improvement is seen, treatment can be extended for up to 5 additional days | |
Pediatric Patients 3.5 – 40 kg | Mechanical Ventilation and/or ECMO | 5 mg/kg IV on day 1 | 2.5 mg/kg IV for 9 days | Use Remdesivir for injection lyophilized powder ONLY |
No mechanical ventilation or ECMO | 5 mg/kg IV on day 1 | 2.5 mg/kg IV for 4 days | Use Remdesivir for injection lyophilized powder ONLY If no clinical improvement is seen, treatment can be extended for up to 5 additional days |
OR, AS DIRECTED BY PHYSICIAN.
COMPOSITION
Remicov 100 mg: Each Box contains one vial of Remdesivir INN 100 mg Lyophilized powder for IV Infusion and two ampoule of Water for Injection BP along with a complementary pouch inside.